Amit Yoran - Feb 17, 2023 Form 4 Insider Report for Tenable Holdings, Inc. (TENB)

Signature
/s/ David Bartholomew, Attorney-in-Fact
Stock symbol
TENB
Transactions as of
Feb 17, 2023
Transactions value $
-$141,118
Form type
4
Date filed
2/22/2023, 07:15 PM
Previous filing
Jan 3, 2023
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TENB Common Stock Options Exercise $0 +10.7K +7.04% $0.00 163K Feb 17, 2023 Direct
transaction TENB Common Stock Sale -$141K -3.29K -2.02% $42.88 159K Feb 21, 2023 Direct F1
holding TENB Common Stock 350K Feb 17, 2023 By Grantor Retained Annuity Trust F2
holding TENB Common Stock 246K Feb 17, 2023 By Trust F3
holding TENB Common Stock 180K Feb 17, 2023 By Grantor Retained Annuity Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENB Restricted Stock Units Options Exercise $0 -10.7K -11.11% $0.00 85.5K Feb 17, 2023 Common Stock 10.7K Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 The Trustee of the Amit Yoran GRAT A is Amit Yoran.
F3 The Trustees of the Amit Yoran 2020 Family Trust are Dov Yoran and David Redling.
F4 The Trustee of the Amit Yoran GRAT B is Amit Yoran.
F5 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F6 25% of the shares underlying the RSUs vested on February 17, 2022, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.